Collegium Pharmaceutical Inc (COLL)
30.40
+0.40
(+1.33%)
USD |
NASDAQ |
Nov 21, 16:00
30.40
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Debt to Equity Ratio: 3.702 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.702 |
| June 30, 2024 | 2.552 |
| March 31, 2024 | 2.805 |
| December 31, 2023 | 3.414 |
| September 30, 2023 | 3.975 |
| June 30, 2023 | 3.759 |
| March 31, 2023 | 4.442 |
| December 31, 2022 | 3.598 |
| September 30, 2022 | 3.669 |
| June 30, 2022 | 3.776 |
| March 31, 2022 | 3.920 |
| December 31, 2021 | 1.232 |
| September 30, 2021 | 1.042 |
| June 30, 2021 | 1.080 |
| March 31, 2021 | 1.676 |
| December 31, 2020 | 1.382 |
| September 30, 2020 | 1.546 |
| Date | Value |
|---|---|
| June 30, 2020 | 1.778 |
| March 31, 2020 | 2.034 |
| December 31, 2019 | 0.1315 |
| September 30, 2019 | 0.1365 |
| June 30, 2019 | 0.134 |
| March 31, 2019 | 0.1332 |
| December 31, 2018 | 0.1256 |
| September 30, 2018 | 0.1625 |
| June 30, 2018 | 0.1391 |
| March 31, 2018 | 0.1266 |
| December 31, 2017 | 0.0142 |
| September 30, 2017 | 0.0223 |
| June 30, 2017 | 0.0295 |
| March 31, 2017 | 0.0304 |
| December 31, 2016 | 0.0307 |
| September 30, 2016 | 0.0648 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1315
Minimum
Dec 2019
4.442
Maximum
Mar 2023
2.576
Average
2.679
Median
Debt to Equity Ratio Benchmarks
| Pfizer Inc | 0.7219 |
| Context Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.635B |
| Total Liabilities (Quarterly) | 1.401B |
| Shareholders Equity (Quarterly) | 234.28M |
| Current Ratio | 0.966 |
| Net Debt Paydown Yield | -1.81% |